Zheng Boyang, Vincent Catherine, Fritzler Marvin J, Senécal Jean-Luc, Koenig Martial, Joyal France
From the Department of Internal Medicine, University of Montreal Hospital Center (CHUM), Hôpital Notre-Dame, Montreal, Quebec; the Department of Hepatology, CHUM, Hôpital St. Luc, Montreal, Quebec; the Department of Rheumatology, CHUM, Hôpital Notre-Dame, Montreal, Quebec; and the Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.
B. Zheng, MD, Department of Internal Medicine, CHUM, Hôpital Notre-Dame; C. Vincent, MD, Department of Hepatology, CHUM, Hôpital St. Luc; M.J. Fritzler, MD, PhD, Faculty of Medicine, University of Calgary; J.L. Senécal, MD, Department of Rheumatology, CHUM, Hôpital Notre-Dame; M. Koenig, MD, MSc, Department of Internal Medicine, CHUM, Hôpital Notre-Dame; F. Joyal, MD, MSc, Department of Internal Medicine, CHUM, Hôpital Notre-Dame.
J Rheumatol. 2017 Jan;44(1):33-39. doi: 10.3899/jrheum.160243. Epub 2016 Oct 15.
Systemic sclerosis (SSc) is a well-established disease associated with primary biliary cholangitis (PBC). However, the original 1980 American College of Rheumatology (ACR) criteria have poor sensitivity, especially for the detection of earlier SSc in previous studies. The objective was to evaluate the prevalence of SSc in patients with PBC using more sensitive 2001 LeRoy and Medsger criteria and the 2013 ACR/European League Against Rheumatism (EULAR) classification criteria. The secondary objective was to evaluate the frequency of individual clinical features.
One hundred consecutive patients with PBC without previously diagnosed SSc were recruited between 2005 and 2007 from a tertiary care gastroenterology clinic. All patients underwent a complete clinical examination, determination of SSc-specific antibodies, and a nailfold capillary microscopy. Fulfillment of the 3 different criteria sets was analyzed, along with individual disease features.
Of 100 patients with PBC, 1% met the ACR 1980 criteria, 22% met the 2001 LeRoy and Medsger criteria for early SSc, and 17% the 2013 ACR/EULAR criteria. Raynaud phenomenon, SSc-related antibodies, and SSc capillaroscopic patterns were the most prevalent findings, with the highest sensitivities to help guide future screening.
Our data show a high prevalence of SSc in patients with PBC with probable underestimation by previous studies using the original ACR criteria. Comorbid SSc should be actively searched for based on newly described criteria to improve detection and increase benefits of earlier treatment.
系统性硬化症(SSc)是一种与原发性胆汁性胆管炎(PBC)相关的既定疾病。然而,1980年美国风湿病学会(ACR)的原始标准敏感性较差,尤其是在先前研究中对早期SSc的检测。目的是使用更敏感的2001年勒罗伊和梅兹格标准以及2013年ACR/欧洲抗风湿病联盟(EULAR)分类标准评估PBC患者中SSc的患病率。次要目的是评估个体临床特征的频率。
2005年至2007年间,从一家三级医疗胃肠病诊所招募了100例先前未诊断出SSc的PBC连续患者。所有患者均接受了全面的临床检查、SSc特异性抗体检测和甲襞毛细血管显微镜检查。分析了3种不同标准集的符合情况以及个体疾病特征。
在100例PBC患者中,1%符合1980年ACR标准,22%符合2001年勒罗伊和梅兹格早期SSc标准,17%符合2013年ACR/EULAR标准。雷诺现象、SSc相关抗体和SSc毛细血管镜检查模式是最常见的发现,具有最高的敏感性,有助于指导未来的筛查。
我们的数据显示PBC患者中SSc的患病率很高,先前使用原始ACR标准的研究可能低估了这一患病率。应根据新描述的标准积极寻找合并的SSc,以改善检测并增加早期治疗的益处。